DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines
Open Access
- 14 April 2020
- journal article
- review article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (7), 1512-1517
- https://doi.org/10.1182/bloodadvances.2019000840
Abstract
Venous thromboembolism (VTE) is a relatively frequent complication in hospitalized patients, especially in those with risk factors. The benefit of using direct oral anticoagulants (DOACs) for prevention is controversial. This systematic review was performed as part of the American Society of Hematology (ASH) guidelines on VTE, developed in partnership with McMaster University. MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Epistemonikos were used as data sources from date of inception to November 2019. We included randomized trials in patients hospitalized for an acute medical disease, evaluating any DOACs vs other pharmacological prophylaxis, and included 3 trials with low risk of bias. We analyzed the effects of DOACs vs low-molecular-weight heparins (LMWHs) at 2 different time points: at the end of the short-term treatment phase (both drugs given for the same period of time) and at the end of the extended prophylaxis period (extended DOACs vs a shorter course of LMWHs). We observed that the use of DOACs did not reduce the risk of pulmonary embolism or symptomatic deep venous thrombosis (DVT) in comparison with LMWHs. However, the risk of major bleeding was slightly increased. Additionally, we observed that the benefit of DOACs previously reported was largely based on the reduction of asymptomatic DVT and was not apparent when only symptomatic events were considered. The use of DOACs in hospitalized medical patients slightly increases the risk of major bleeding with no appreciable benefit over LMWHs.This publication has 15 references indexed in Scilit:
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical PatientsThe New England Journal of Medicine, 2016
- Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trialsThrombosis and Haemostasis, 2015
- Venous Thromboembolism in Older Adults: A Community-based StudyThe American Journal of Medicine, 2014
- Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish National Discharge DatabaseEuropean Journal of Internal Medicine, 2013
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical PatientsThe New England Journal of Medicine, 2013
- Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee ReplacementAnnals of Internal Medicine, 2012
- Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill PatientsThe New England Journal of Medicine, 2011
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- Rates of venous thromboembolism occurrence in medical patients among the insured populationThrombosis and Haemostasis, 2009
- Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta‐analysisJournal of Internal Medicine, 2007